BMS-986442

N/A

Report date: 2024/10/22 20:00:07

Base Information

Drug NameBMS-986442

Drug Alias NameAGEN-1777BMS-986442BMS-986-442

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-T cell immunoglobulin and ITIM domainsT-cell surface protein tactile antagonists

TargetsT cell immunoglobulin and ITIM domainsT-cell surface protein tactile

Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungStomach Neoplasms +[6]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesPolandItaly +[5]

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAgenus Inc

China Registration ClassN/A

Develop Information

Active CompaniesAgenus Inc Bristol Myers Squibb Srlcompany

Inactive CompaniesN/A

Active IndicationsStomach NeoplasmsColorectal NeoplasmsBreast Neoplasms

Inactive IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungNeoplasms

Other Information

ATC CodeN/A